The forecast for malignant neoplasms mortality among males in the US suggests a steady increase from 321.09 thousand in 2024 to 324.61 thousand by 2028. Compared to the last recorded data from 2023, this reflects a slow but consistent upward trend in mortality rates. Year-on-year analysis indicates a minimal average increase of around 0.5% annually from 2024 to 2028. As we progress through this decade, the compound annual growth rate (CAGR) from 2023 to 2028 is expected to be modest.
Future trends to watch for include advancements in early detection and treatment, potential impacts of healthcare policy changes, and lifestyle shifts that may influence the patterns of cancer incidence and mortality.
